Estrella Immunopharma (Estrella Immunopharma) Days Sales Outstanding : 0.00 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Estrella Immunopharma Days Sales Outstanding?

Estrella Immunopharma's average Accounts Receivable for the three months ended in Mar. 2024 was $0.00 Mil. Estrella Immunopharma's Revenue for the three months ended in Mar. 2024 was $0.00 Mil.

The historical rank and industry rank for Estrella Immunopharma's Days Sales Outstanding or its related term are showing as below:

ESLA's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.66
* Ranked among companies with meaningful Days Sales Outstanding only.

Estrella Immunopharma's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Mar. 2024 (0.00).

Estrella Immunopharma Days Sales Outstanding Historical Data

The historical data trend for Estrella Immunopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Estrella Immunopharma Days Sales Outstanding Chart

Estrella Immunopharma Annual Data

Trend

Jun21

Days Sales Outstanding

Estrella Immunopharma Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Estrella Immunopharma's Days Sales Outstanding

For the Biotechnology subindustry, Estrella Immunopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Estrella Immunopharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Days Sales Outstanding falls into.

Estrella Immunopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Estrella Immunopharma's Days Sales Outstanding for the fiscal year that ended in Jun. 2021 is calculated as

	Days Sales Outstanding (A: Jun. 2021 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: Jun. 2021 ))	/	count )	/	Revenue (A: Jun. 2021 )	*	Days in Period
=	( (	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Estrella Immunopharma's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Estrella Immunopharma (NAS:ESLA) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Estrella Immunopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Estrella Immunopharma Inc (NAS:ESLA) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

5858 Horton Street, Suite 170, Emeryville, CA, USA, 94608

Website

https://www.estrellabio.com

Estrella Immunopharma Inc is a preclinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer.

Estrella Immunopharma (Estrella Immunopharma) Headlines

No Headlines